Adult Following dual or triple therapy in both treatment groups (Simulect vs Placebo or ATG/ALG): Constipation, UTI, pain, nausea, peripheral oedema, HTN, anaemia, headache, hyperkalaemia, hypercholesterolaemia, postop wound complication, increased wt, increased blood creatinine, hypophosphataemia, diarrhoea, upper resp tract infection.
Ped patient Following dual therapy in both (<35 kg vs ≥35 kg) cohorts: UTI, hypertrichosis, rhinitis, pyrexia, HTN, upper resp tract & viral infection, sepsis & constipation.